NEW DELHI, Jan 01: The subject expert committee of Central Drugs Standard Control Organization (CDSCO) has recommended Oxford-AstraZeneca COVID-19 vaccine, Covishield, for emergency use authorisation to Drugs Controller General of India (DCGI).
The CDSCO recommendation comes with certain conditions.
Covishield would be the first vaccine to be given the go-ahead by drug regulators in India. The vaccine has been manufactured by AstraZeneca's local partner Serum Institute of India (SII).
|